BMC Neurology

official impact factor 2.80

Open Access Highly Access

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

Carsten Saft*, Thorsten Lauter, Peter H Kraus, Horst Przuntek and Juergen E Andrich

BMC Neurology 2006, 6:11 doi:10.1186/1471-2377-6-11

Accesses  

  • Last 30 days: 81 accesses
  • Last 365 days: 652 accesses
  • All time: 6635 accesses